SPRB: Spruce Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5.08
Enterprise Value ($M) -31.93
Book Value ($M) 28.82
Book Value / Share 0.70
Price / Book 0.18
NCAV ($M) 27.82
NCAV / Share 0.67
Price / NCAV 0.18

Profitability (mra)
Return on Invested Capital (ROIC) -1.68
Return on Assets (ROA) -0.61
Return on Equity (ROE) -0.80

Liquidity (mrq)
Quick Ratio 2.90
Current Ratio 2.90

Balance Sheet (mrq) ($M)
Current Assets 44.21
Assets 45.21
Liabilities 16.39
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 4.91
Operating Income -56.15
Net Income -53.04

Cash Flow Statement (mra) ($M)
Cash From Operations -55.96
Cash from Investing 0.00
Cash from Financing -1.62

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Rosalind Advisors, Inc. 0.00
01-10 13D/A RiverVest Venture Fund III, L.P. 4.20 -50.12
11-14 13G/A 5AM Opportunities II, L.P. 4.10 -57.14
11-14 13G/A Armistice Capital, Llc 4.99 -2.72
11-12 13G/A Radoff Bradley Louis 9.60 40.71
2024-03-28 13D/A Novo Holdings A/S 3.90 -39.91

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 1,088,705 3,813,645 28.55
2025-04-16 1,257,080 3,715,228 33.84
2025-04-15 6,793,775 27,548,861 24.66
2025-04-14 13,150 104,741 12.55

(click for more detail)

Similar Companies
SNTI – Senti Biosciences, Inc. SNYR – Synergy CHC Corp.
SONN – Sonnet BioTherapeutics Holdings, Inc. SRZN – Surrozen, Inc.
SXTC – China SXT Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io